Venus Concept (VERO) Company Report

Venus Concept Inc. entered into a Twenty Fifth Bridge Loan Amendment on January 29, 2026, which extended the maturity date of its Bridge Loan from January 31, 2026 to February 13, 2026.
The amendment also increased the delayed draw commitment under the Bridge Loan from $26,000,000 to $28,000,000.
On the same date, the company received a $2,000,000 drawdown under the Loan and Security Agreement, with the proceeds intended for general working capital purposes.
Lenders waived certain minimum liquidity requirements for both the Bridge Loan and the Main Street Priority Loan through February 13, 2026, and permitted the company to apply the February 8, 2026 cash interest payment due under the Main Street Priority Loan to its outstanding principal balance.

4 days ago

Venus Concept Reports Q3 2025 Results, Announces New Product Clearance, and Updates on Hair Business Sale

VERO

Earnings

Product Launch

M&A

Venus Concept reported Q3 2025 total revenue of $13.8 million, an 8% decrease year-over-year, driven by softness in the hair restoration business, despite a 2% increase in energy-based device sales. The company posted a net loss of $22.6 million, or $12.14 per share.
The company announced 510(k) clearance for its new Venus Nova multi-application platform on November 10th, with a limited commercial launch planned for December to contribute to sequential growth in Q4.
Challenges persist in closing the sale of the Venus Hair business to MHG Coal Limited, leading Venus Concept to seek assistance from the Delaware Court.
As of September 30, 2025, the company's balance sheet showed $5.9 million in cash and cash equivalents and total debt obligations of approximately $30.1 million, reflecting significant progress in debt reduction, including $11.4 million in debt-to-equity exchanges during Q3 2025.
Venus Concept is not providing full-year 2025 financial guidance due to ongoing strategic evaluations and current market conditions.

Nov 13, 2025, 1:00 PM

Venus Concept Inc. Announces Q3 2025 Financial Results and Venus NOVA Clearance

VERO

Earnings

Product Launch

Convertible Preferred Issuance

Venus Concept Inc. reported total revenue of $13.8 million for the third quarter of 2025, representing an 8% decrease year-over-year and a 12% decrease quarter-over-quarter, primarily due to a decline in its Hair Restoration business.
For Q3 2025, the company recorded a GAAP net loss of $22.5 million and an Adjusted EBITDA loss of $7.8 million.
On November 10, 2025, Venus Concept received FDA 510(k) clearance for its new Venus NOVA multi-application platform, with a limited commercial launch targeted for December 2025.
The company reduced its total debt obligations by 24% compared to December 31, 2024, through debt-to-equity exchanges totaling $18.0 million.
Venus Concept is not providing financial guidance for fiscal year 2025 due to ongoing evaluations of strategic alternatives and potential trade disruptions.

Nov 13, 2025, 12:05 PM

Venus Concept Announces Q3 2025 Financial Results

VERO

Earnings

Convertible Preferred Issuance

Legal Proceedings

Venus Concept reported total revenue of $13.8 million for the third quarter of 2025, an 8% decrease year-over-year, and a GAAP net loss of $22.5 million.
The Adjusted EBITDA loss for the third quarter of 2025 was $7.8 million, compared to $5.9 million in the prior year.
On September 30, 2025, the company exchanged $11.5 million of subordinated convertible notes for Series Y preferred stock, contributing to a 24% total debt reduction compared to December 31, 2024.
Venus Concept announced 510(k) clearance for its new Venus NOVA on November 10, 2025, with a limited commercial launch targeted for December.
The pending sale of the Venus Hair Business is delayed, and the company has sought assistance from the Delaware Court of Chancery to facilitate the closing of this transaction.

Nov 13, 2025, 12:00 PM

Venus Concept announces debt-to-equity exchange transaction

VERO

Debt Issuance

Convertible Preferred Issuance

Venus Concept Inc. completed an $11.48 million debt-to-equity exchange transaction on September 30, 2025.
In this transaction, the company exchanged subordinated convertible notes held by Madryn Asset Management, LP for 545,335 shares of its Series Y preferred stock.
This exchange reduced Venus Concept's total debt obligations to approximately $30.1 million, representing a 24% reduction from $39.7 million outstanding as of December 31, 2024.
The Series Y Preferred Shares issued in the exchange were priced at $21.05 per share.

Oct 2, 2025, 8:11 PM

Venus Concept Completes Debt-to-Equity Exchange

VERO

Convertible Preferred Issuance

On September 30, 2025, Venus Concept Inc. exchanged the full $11.48 million balance of its subordinated convertible notes held by affiliates of Madryn Asset Management, LP for 545,335 shares of its Series Y preferred stock.
Following this transaction, the company's total debt obligations were approximately $30.1 million.
This represents a 24% reduction in total debt compared to the $39.7 million outstanding as of December 31, 2024.
The company's CEO, Rajiv De Silva, stated that this debt exchange reduces the overall debt balance and optimizes the capital structure.

Oct 2, 2025, 8:05 PM

Venus Concept Amends Loan Terms and Waives Liquidity Covenants

VERO

Debt Issuance

Venus Concept Inc. (VERO) entered into a Nineteenth Bridge Loan Amendment on August 31, 2025, with Madryn Health Partners, LP and Madryn Health Partners (Cayman Master), LP, extending the maturity date of its Bridge Loan from August 31, 2025, to September 30, 2025.
The company also entered into a Consent Agreement for its Main Street Priority Loan on August 31, 2025, which waives certain minimum liquidity requirements under the MSLP Loan Agreement through September 30, 2025. This agreement also consents to the September 2025 interest payment being added to the outstanding principal amount of the loan (PIK).
A separate Notes Consent Agreement was executed on August 31, 2025, waiving certain minimum liquidity requirements under the 2025 Notes through September 30, 2025.